Guardant Health, Inc. (GH)
106.45
-3.72
(-3.38%)
USD |
NASDAQ |
Jan 12, 10:57
Guardant Health Research and Development Expense (Annual): 347.75M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| EXACT Sciences Corp. | 431.21M |
| Illumina, Inc. | 1.167B |
| Natera, Inc. | 404.14M |
| Quest Diagnostics, Inc. | -- |
| GeneDx Holdings Corp. | 44.80M |